应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
06160 百济神州
交易中 04-23 13:14:48
153.100
+3.600
+2.41%
最高
155.000
最低
149.600
成交量
332.91万
今开
155.000
昨收
149.500
日振幅
3.61%
总市值
2,145亿
流通市值
1,969亿
总股本
14.01亿
成交额
5.07亿
换手率
0.26%
流通股本
12.86亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
百济神州(ONC)盘前涨超8% 机构升其目标价至317美元
金吾财讯 · 04-22 10:47
百济神州(ONC)盘前涨超8% 机构升其目标价至317美元
A股午后医药板块持续走高,创新药方向继续领涨,众生药业、华森制药、富士莱涨停,百利天恒、诺诚健华、新诺威、百济神州创历史
美港电讯 · 04-22 05:47
A股午后医药板块持续走高,创新药方向继续领涨,众生药业、华森制药、富士莱涨停,百利天恒、诺诚健华、新诺威、百济神州创历史
港股医药逆势走强 港股医药ETF涨超3% 冲击四连涨
东方财富证券 · 04-22 03:10
港股医药逆势走强 港股医药ETF涨超3% 冲击四连涨
港股创新药板块走强,歌礼制药(01672.HK)涨超20%,荣昌生物(09995.HK)、石药集团(01093.HK)涨
美港电讯 · 04-22 01:49
港股创新药板块走强,歌礼制药(01672.HK)涨超20%,荣昌生物(09995.HK)、石药集团(01093.HK)涨
百济神州盘中异动 股价大涨3.01%报143.900港元
市场透视 · 04-22 01:30
百济神州盘中异动 股价大涨3.01%报143.900港元
万家基金黄兴亮旗下万家行业优选一季报最新持仓,重仓百济神州
证券之星 · 04-20 21:23
万家基金黄兴亮旗下万家行业优选一季报最新持仓,重仓百济神州
百济神州BCL-2抑制剂索托克拉片拟纳入优先审评
药事纵横 · 04-17
百济神州BCL-2抑制剂索托克拉片拟纳入优先审评
Guggenheim:重申BeiGene(ONC.US)评级,由买入调整至买入评级。
金融界 · 04-16
Guggenheim:重申BeiGene(ONC.US)评级,由买入调整至买入评级。
百济神州盘中异动 早盘快速跳水3.03%
市场透视 · 04-16
百济神州盘中异动 早盘快速跳水3.03%
港股生物医药板块持续走弱,泰格医药(03347.HK)跌超4%,百济神州(06160.HK)跌超2%,药明康德(0235
美港电讯 · 04-15
港股生物医药板块持续走弱,泰格医药(03347.HK)跌超4%,百济神州(06160.HK)跌超2%,药明康德(0235
百济神州因董事行使购股权而发行54.288万股股份
智通财经网 · 04-14
百济神州因董事行使购股权而发行54.288万股股份
百济神州(06160)因董事行使购股权而发行54.288万股股份
智通财经 · 04-14
百济神州(06160)因董事行使购股权而发行54.288万股股份
【创新药概念反复活跃,一品红涨超10%续创历史新高】一品红涨超10%,股价续创历史新高,东诚药业涨停,悦康药业、科兴制药、智翔金泰、前沿生物、热景生物、百济神州等涨幅靠前。
金融界 · 04-14
【创新药概念反复活跃,一品红涨超10%续创历史新高】一品红涨超10%,股价续创历史新高,东诚药业涨停,悦康药业、科兴制药、智翔金泰、前沿生物、热景生物、百济神州等涨幅靠前。
港股生物医药板块盘初走强,再鼎医药涨超12%,君实生物涨超5%,百济神州、药明康德等跟涨。
金融界 · 04-14
港股生物医药板块盘初走强,再鼎医药涨超12%,君实生物涨超5%,百济神州、药明康德等跟涨。
港股生物医药板块盘初走强,再鼎医药(09688.HK)涨超12%,君实生物(01877.HK)涨超5%,百济神州(061
美港电讯 · 04-14
港股生物医药板块盘初走强,再鼎医药(09688.HK)涨超12%,君实生物(01877.HK)涨超5%,百济神州(061
百济神州03月11日获主力加仓1669万元
市场透视 · 03-11
百济神州03月11日获主力加仓1669万元
深圳近450个“AI+医疗”产品落地,港股创新药ETF涨超1%,百济神州涨超3%
21世纪经济报道 · 03-11
深圳近450个“AI+医疗”产品落地,港股创新药ETF涨超1%,百济神州涨超3%
百济神州盘中异动 股价大涨3.00%
市场透视 · 03-11
百济神州盘中异动 股价大涨3.00%
百济神州因购股权获行使而发行约103.36万股
新浪港股 · 03-11
百济神州因购股权获行使而发行约103.36万股
注意!百济神州将于4月28日召开股东大会
每日经济新闻 · 03-10
注意!百济神州将于4月28日召开股东大会
加载更多
公司概况
公司名称:
百济神州
所属市场:
SEHK
上市日期:
--
主营业务:
BeiGene Ltd是一家全球生物技术公司,致力于为全球癌症患者发现和开发肿瘤治疗方法。该公司已发现并开发三种批准药物,包括BRUKINSA,一种布鲁顿酪氨酸激酶的小分子抑制剂,用于治疗各种血癌;TEVIMBRA(tislelizumab),一种抗PD-1抗体免疫疗法,用于治疗各种实体瘤和血癌;以及是聚ADP核糖聚合酶1(PARP1)和PARP2的选择性小分子抑制剂pamiparib。该公司已获得在美国、中华人民共和国(中国)、欧盟、英国、加拿大、澳大利亚和其他国际市场销售BRUKINSA,在欧盟和中国销售替雷利珠单抗,以及在中国销售帕米帕尼的批准。它还专注于在Amgen Inc独家授权下在中国商业化癌症药物,如XGEVA、BLINCYTO、KYPROLIS等。
发行价格:
--
{"stockData":{"symbol":"06160","market":"HK","secType":"STK","nameCN":"百济神州","latestPrice":153.1,"timestamp":1745385281527,"preClose":149.5,"halted":0,"volume":3329080,"delay":0,"floatShares":1286000000,"shares":1401000000,"eps":-3.654969081443435,"marketStatus":"交易中","change":3.6,"latestTime":"04-23 13:14:48","open":155,"high":155,"low":149.6,"amount":506588291,"amplitude":0.03612,"askPrice":153.2,"askSize":2700,"bidPrice":153.1,"bidSize":2300,"shortable":3,"etf":0,"ttmEps":-3.654969081443435,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1745395800000},"marketStatusCode":2,"adr":0,"listingDate":1533657600000,"exchange":"SEHK","adjPreClose":149.5,"openAndCloseTimeList":[[1745371800000,1745380800000],[1745384400000,1745395200000]],"volumeRatio":1.004188,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688235","market":"SH","secType":"STK","nameCN":"百济神州","latestPrice":248.58,"timestamp":1745385282000,"preClose":249.62,"halted":0,"volume":1394100,"delay":0,"premium":"-42.06"}},"requestUrl":"/m/hq/s/06160","defaultTab":"news","newsList":[{"id":"2529371912","title":"百济神州(ONC)盘前涨超8% 机构升其目标价至317美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529371912","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529371912?lang=zh_cn&edition=full","pubTime":"2025-04-22 18:47","pubTimestamp":1745318837,"startTime":"0","endTime":"0","summary":"金吾财讯 | 百济神州(ONC)盘前涨超8%,截至发稿,报249.32美元。消息面上,摩根大通分析师杰西卡·费伊维持百济神州评级为增持,并将目标价从311美元上调至317美元。此外,国盛证券表示,公司产品已实现自主出海,全球商业化能力强劲,产品管线聚焦潜在同类最佳目标,创新性突出。该行看好公司长期发展。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250107/ZDg5MDljMjM3Zjg4MTM1NjQzMDIzNjY=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/ZDg5MDljMjM3Zjg4MTM1NjQzMDIzNjY=.png"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"287722","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONC","06160","688235"],"gpt_icon":0},{"id":"2529701316","title":"A股午后医药板块持续走高,创新药方向继续领涨,众生药业、华森制药、富士莱涨停,百利天恒、诺诚健华、新诺威、百济神州创历史","url":"https://stock-news.laohu8.com/highlight/detail?id=2529701316","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529701316?lang=zh_cn&edition=full","pubTime":"2025-04-22 13:47","pubTimestamp":1745300842,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["002294","688506","688235","01349","BK0077","159992","688505","BK1583","ONC","159982","06160","LU1969619763.USD","BK1161","BK0196","301258","BK1500","09969","399300","BK0239","002317","688428","BK0187","688091","300765","BK1574","BK0226","BK1191","BK0028","LU0307460666.USD","159938","LU2328871848.SGD","BK4139","688068","BK1588","LU0588546209.SGD","002907","BK0183","BK1515","BK0188","09939","06978"],"gpt_icon":0},{"id":"2529391901","title":"港股医药逆势走强 港股医药ETF涨超3% 冲击四连涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2529391901","media":"东方财富证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529391901?lang=zh_cn&edition=full","pubTime":"2025-04-22 11:10","pubTimestamp":1745291400,"startTime":"0","endTime":"0","summary":"4月22日,港股市场集体震荡环境下,港股医药带头领涨,港股医药ETF上涨3.10%,冲击4连涨。成分股石药集团、百济神州、信达生物、再鼎医药、康方生物上涨超 5%。港股医药ETF紧密跟踪中证港股通医药卫生综合指数,中证港股通医药卫生综合指数从港股通范围内选取50只流动性较好、市值较大的医疗卫生行业上市公司证券作为指数样本,以反映港股通范围内医药卫生上市公司证券的整体表现。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422111145a6c32f7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422111145a6c32f7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999004220.SGD","LU1226287529.USD","LU1152091168.USD","LU0880133367.SGD","LU1960683339.HKD","LU0501845795.SGD","LU0140636845.USD","LU1152091754.HKD","IE00BZ08YS42.EUR","HSTECH","LU1226287875.USD","06160","LU0067412154.USD","LU0072913022.USD","LU1226288253.USD","09688","IE0008369823.USD","LU1993786604.SGD","LU1226288170.HKD","IE00BZ08YT58.USD","IE00BZ08YR35.GBP","01093","LU1008478684.HKD","IE00B5MMRT66.SGD","LU0326950275.SGD","09926","LU1951186391.HKD","IE0008368742.USD","01801","IE00B543WZ88.USD","LU1226287792.SGD","BK1521","BK1191","LU1807302812.USD","BK1515","IE00B031HY20.USD"],"gpt_icon":1},{"id":"2529362752","title":"港股创新药板块走强,歌礼制药(01672.HK)涨超20%,荣昌生物(09995.HK)、石药集团(01093.HK)涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2529362752","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529362752?lang=zh_cn&edition=full","pubTime":"2025-04-22 09:49","pubTimestamp":1745286560,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0239","LU0501845795.SGD","159992","688235","BK1588","LU1226287792.SGD","LU0307460666.USD","BK1583","IE0008368742.USD","LU1226288253.USD","IE00BZ08YT58.USD","BK4614","07226","09995","LU1152091754.HKD","01801","01672","HSTECH","LU1951186391.HKD","LU1993786604.SGD","BK4139","LU1152091168.USD","HSCEI","LU1226287529.USD","BK1574","01093","IE00BZ08YS42.EUR","LU1226288170.HKD","ONC","LU0880133367.SGD","IE00B5MMRT66.SGD","LU0140636845.USD","BK1500","LU1807302812.USD","SG9999004220.SGD","06978","06160","YANG","688331","BK1521","IE00B031HY20.USD","LU2488822045.USD","LU1008478684.HKD","LU1969619763.USD","LU2328871848.SGD","IE0008369823.USD","01477","BK1515","IE00B543WZ88.USD","BK1161"],"gpt_icon":0},{"id":"2529036409","title":"百济神州盘中异动 股价大涨3.01%报143.900港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529036409","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529036409?lang=zh_cn&edition=full","pubTime":"2025-04-22 09:30","pubTimestamp":1745285425,"startTime":"0","endTime":"0","summary":"2025年04月22日早盘09时30分,百济神州股票出现异动,股价急速拉升3.01%。截至发稿,该股报143.900港元/股,成交量12.01万股,换手率0.01%,振幅3.15%。资金方面,该股资金流入679.035万港元,流出198.031万港元。百济神州股票所在的生物技术行业中,整体涨幅为0.51%。百济神州公司简介:百济神州是一家全球性、商业阶段的生物科技公司,专注于研究、开发、生产以及商业化创新型药物。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422093025973ff6d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422093025973ff6d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","06160","688235"],"gpt_icon":0},{"id":"2529899018","title":"万家基金黄兴亮旗下万家行业优选一季报最新持仓,重仓百济神州","url":"https://stock-news.laohu8.com/highlight/detail?id=2529899018","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529899018?lang=zh_cn&edition=full","pubTime":"2025-04-21 05:23","pubTimestamp":1745184237,"startTime":"0","endTime":"0","summary":"证券之星消息,4月21日万家基金旗下黄兴亮管理的万家行业优选混合型基金(LOF)公布一季报,近1年净值增长率63.21%。与上一季度相比,该基金前十大重仓股新增格科微;其中百济神州持仓占比10.06%,为该基金第一大重仓股;中微公司等退出前十大重仓股;详细数据如下:以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042100001367.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0588546209.SGD","LU1969619763.USD","06160","688235","BK1500","LU0307460666.USD","BK1161","BK1583","BK0239","LU2328871848.SGD","BK1588"],"gpt_icon":0},{"id":"2528725248","title":"百济神州BCL-2抑制剂索托克拉片拟纳入优先审评","url":"https://stock-news.laohu8.com/highlight/detail?id=2528725248","media":"药事纵横","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528725248?lang=zh_cn&edition=full","pubTime":"2025-04-18 00:03","pubTimestamp":1744905813,"startTime":"0","endTime":"0","summary":"4月17日,中国国家药监局药品审评中心宣布,将百济神州自主研发的新一代BCL-2抑制剂索托克拉片的两项适应症纳入优先审评程序。在这样的背景下,百济神州的索托克拉片展现出后来居上的潜力。目前百济神州正在全球推进索托克拉片联合自家明星产品泽布替尼的三期试验,这种\"双靶点围剿\"策略在血液肿瘤治疗中已成趋势。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418003507a6be38e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418003507a6be38e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06160","ONC","BK4139","688235"],"gpt_icon":0},{"id":"2527247419","title":"Guggenheim:重申BeiGene(ONC.US)评级,由买入调整至买入评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2527247419","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527247419?lang=zh_cn&edition=full","pubTime":"2025-04-16 22:51","pubTimestamp":1744815074,"startTime":"0","endTime":"0","summary":"Guggenheim:重申BeiGene(ONC.US)评级,由买入调整至买入评级。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/16225149602929.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ONC","06160"],"gpt_icon":0},{"id":"2527404954","title":"百济神州盘中异动 早盘快速跳水3.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527404954","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527404954?lang=zh_cn&edition=full","pubTime":"2025-04-16 09:31","pubTimestamp":1744767081,"startTime":"0","endTime":"0","summary":"2025年04月16日早盘09时31分,百济神州股票出现异动,股价大幅跳水3.03%。截至发稿,该股报140.600港元/股,成交量27.7万股,换手率0.02%,振幅2.28%。机构评级方面,在所有31家参与评级的机构中,97%的券商给予买入建议,3%的券商给予持有建议,无券商给予卖出建议。百济神州股票所在的生物技术行业中,整体跌幅为0.30%。百济神州公司简介:百济神州是一家全球性、商业阶段的生物科技公司,专注于研究、开发、生产以及商业化创新型药物。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504160931219739381d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504160931219739381d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688235","06160"],"gpt_icon":0},{"id":"2527456114","title":"港股生物医药板块持续走弱,泰格医药(03347.HK)跌超4%,百济神州(06160.HK)跌超2%,药明康德(0235","url":"https://stock-news.laohu8.com/highlight/detail?id=2527456114","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527456114?lang=zh_cn&edition=full","pubTime":"2025-04-15 15:32","pubTimestamp":1744702361,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1588","LU2328871848.SGD","LU1820825898.SGD","02359","161726","LU1997245177.USD","LU1146622755.USD","HSTECH","LU0052750758.USD","BK0028","BK1141","YANG","BK0174","LU2045819591.USD","BK4139","399441","07226","LU0588546209.SGD","BK4614","LU2125910500.SGD","BK1161","LU2488822045.USD","300347","LU2242644610.SGD","ONC","BK0239","LU0307460666.USD","LU0456842615.SGD","06160","BK1500","603259","BK1583","LU0320764599.SGD","BK0077","LU0708995583.HKD","688235","LU1969619763.USD","03347","BK1576","BK0216","HSCEI","LU1046422090.SGD","LU1997245094.SGD"],"gpt_icon":0},{"id":"2527178201","title":"百济神州因董事行使购股权而发行54.288万股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2527178201","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527178201?lang=zh_cn&edition=full","pubTime":"2025-04-15 07:53","pubTimestamp":1744674819,"startTime":"0","endTime":"0","summary":"智通财经APP讯,百济神州(06160)公布,因一名董事于 2025 年 4月14日行使购股权而发行54.288万股股份,每股发行价0.5美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504150755129737e4b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504150755129737e4b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1500","06160","LU0588546209.SGD","BK1588","BK1583","LU1969619763.USD","BK1161","LU2328871848.SGD","LU0307460666.USD"],"gpt_icon":0},{"id":"2527120473","title":"百济神州(06160)因董事行使购股权而发行54.288万股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2527120473","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527120473?lang=zh_cn&edition=full","pubTime":"2025-04-15 07:53","pubTimestamp":1744674819,"startTime":"0","endTime":"0","summary":"智通财经APP讯,百济神州(06160)公布,因一名董事于 2025 年 4月14日行使购股权而发行54.288万股股份,每股发行价0.5美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1278594.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1969619763.USD","ONC","BK1500","LU2328871848.SGD","688235","BK1583","06160","BK1588","BK1161","BK4139","LU0588546209.SGD","LU0307460666.USD","BK0239"],"gpt_icon":0},{"id":"2527946447","title":"【创新药概念反复活跃,一品红涨超10%续创历史新高】一品红涨超10%,股价续创历史新高,东诚药业涨停,悦康药业、科兴制药、智翔金泰、前沿生物、热景生物、百济神州等涨幅靠前。","url":"https://stock-news.laohu8.com/highlight/detail?id=2527946447","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527946447?lang=zh_cn&edition=full","pubTime":"2025-04-14 09:55","pubTimestamp":1744595733,"startTime":"0","endTime":"0","summary":"一品红涨超10%,股价续创历史新高,东诚药业涨停,悦康药业、科兴制药、智翔金泰、前沿生物、热景生物、百济神州等涨幅靠前。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/14095549514272.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["159992","688221","06978","BK1583","LU1969619763.USD","BK4139","LU0307460666.USD","BK0239","BK1574","688235","688068","LU0588546209.SGD","LU2328871848.SGD","688658","300723","688443","BK1500","BK1588","06160","688136","002675","BK1161","ONC"],"gpt_icon":0},{"id":"2527945141","title":"港股生物医药板块盘初走强,再鼎医药涨超12%,君实生物涨超5%,百济神州、药明康德等跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2527945141","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527945141?lang=zh_cn&edition=full","pubTime":"2025-04-14 09:44","pubTimestamp":1744595082,"startTime":"0","endTime":"0","summary":"港股生物医药板块盘初走强,再鼎医药涨超12%,君实生物涨超5%,百济神州、药明康德等跟涨。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/14094449514121.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02359","LU0588546209.SGD","09688","LU2488822045.USD","BK4526","YANG","BK1583","BK1515","399441","06160","LU2125910500.SGD","LU2328871848.SGD","LU1046422090.SGD","ZLAB","LU2045819591.USD","LU0052750758.USD","LU1969619763.USD","BK1500","LU0320764599.SGD","LU1997245177.USD","01877","BK1576","BK1574","LU1997245094.SGD","BK0239","BK4585","BK1141","LU0307460666.USD","ONC","BK0216","BK1161","LU0708995583.HKD","BK4531","HSTECH","BK4139","BK4614","603259","BK4588","LU2242644610.SGD","688180","LU0456842615.SGD","161726","BK1588","688235","BK4548"],"gpt_icon":0},{"id":"2527945619","title":"港股生物医药板块盘初走强,再鼎医药(09688.HK)涨超12%,君实生物(01877.HK)涨超5%,百济神州(061","url":"https://stock-news.laohu8.com/highlight/detail?id=2527945619","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527945619?lang=zh_cn&edition=full","pubTime":"2025-04-14 09:43","pubTimestamp":1744595016,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU2125910500.SGD","LU1997245094.SGD","LU1046422090.SGD","LU2242644610.SGD","LU0320764599.SGD","02359","BK4614","BK4585","688235","LU0456842615.SGD","HSCEI","01877","BK4548","LU1969619763.USD","BK1574","BK1500","LU1997245177.USD","HSTECH","BK1141","161726","BK4531","LU0307460666.USD","ONC","BK0239","09688","BK1161","LU2045819591.USD","LU0588546209.SGD","LU2328871848.SGD","BK1583","06160","BK4588","ZLAB","LU2488822045.USD","688180","LU0052750758.USD","07226","BK4139","BK1588","399441","603259","BK1515","YANG","BK0216","BK4526","LU0708995583.HKD","BK1576"],"gpt_icon":0},{"id":"2518718909","title":"百济神州03月11日获主力加仓1669万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518718909","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518718909?lang=zh_cn&edition=full","pubTime":"2025-03-11 16:15","pubTimestamp":1741680921,"startTime":"0","endTime":"0","summary":"03月11日, 百济神州股价涨3.21%,报收147.90元,成交金额7.74亿元,换手率0.41%,振幅4.12%,量比0.64。百济神州今日主力资金净流入1669万元,上一交易日主力净流入4415万元。该股近5个交易日下跌1.64%,主力资金累计净流入1.27亿元;近20日主力资金累计净流入7.42亿元,其中净流入天数为18日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311165334abf606be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311165334abf606be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","LU0588546209.SGD","BK1161","BK1588","BK1500","06160","LU0307460666.USD","LU1969619763.USD","LU2328871848.SGD"],"gpt_icon":1},{"id":"2518730385","title":"深圳近450个“AI+医疗”产品落地,港股创新药ETF涨超1%,百济神州涨超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518730385","media":"21世纪经济报道","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518730385?lang=zh_cn&edition=full","pubTime":"2025-03-11 10:22","pubTimestamp":1741659768,"startTime":"0","endTime":"0","summary":"3月11日,港股早盘低开回升,恒生科技指数一度转涨,此前跌超2%,药品及生物科技板块盘中走强,相关ETF方面,港股创新药ETF涨超1%。消息面上,深圳近450个“AI+医疗”产品落地。据深圳市卫健委消息,深圳正推进人工智能技术在16类63个医疗卫生服务场景中落地应用。目前深圳粗略估计已经有近450个人工智能产品在全市医疗卫生机构落地应用。港股创新药ETF紧密跟踪港股通创新药指数,该指数反映港股通生物科技产业上市公司的运行特征。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031110410598a343cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031110410598a343cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688235","06160","BK4139","ONC"],"gpt_icon":0},{"id":"2518731082","title":"百济神州盘中异动 股价大涨3.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518731082","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518731082?lang=zh_cn&edition=full","pubTime":"2025-03-11 09:35","pubTimestamp":1741656916,"startTime":"0","endTime":"0","summary":"2025年03月11日早盘09时35分,百济神州股票出现异动,股价快速上涨3.00%。截至发稿,该股报147.600港元/股,成交量46.91万股,换手率0.04%,振幅2.51%。资金方面,该股资金流入3494.05万港元,流出2312.03万港元。百济神州股票所在的生物技术行业中,整体跌幅为0.41%。其相关个股中,荃信生物-B、百济神州、东曜药业-B涨幅较大,振幅较大的相关个股有方达控股、科伦博泰生物-B、欧康维视生物-B,振幅分别为10.58%、6.59%、6.53%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031109351798a32fb4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031109351798a32fb4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1500","LU2328871848.SGD","BK1583","BK1588","LU0307460666.USD","LU0588546209.SGD","06160","LU1969619763.USD","BK1161","688235"],"gpt_icon":0},{"id":"2518735114","title":"百济神州因购股权获行使而发行约103.36万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2518735114","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518735114?lang=zh_cn&edition=full","pubTime":"2025-03-11 08:31","pubTimestamp":1741653060,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 百济神州(06160)发布公告,该公司因一名董事于2025年3月10日行使购股权而发行约103.36万股。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:卢昱君","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-03-11/doc-inepfvkv2864557.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1500","BK4139","LU1969619763.USD","688235","BK1588","LU0307460666.USD","06160","BK1583","ONC","LU2328871848.SGD","BK0239","BK1161","LU0588546209.SGD"],"gpt_icon":0},{"id":"2518275113","title":"注意!百济神州将于4月28日召开股东大会","url":"https://stock-news.laohu8.com/highlight/detail?id=2518275113","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518275113?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:41","pubTimestamp":1741617705,"startTime":"0","endTime":"0","summary":"每经AI快讯,百济神州(SH688235,收盘价:218.38元)3月10日发布公告称,2025年4月28日21点30分,公司将在MourantGovernanceServicesLimited的办公室,位于94SolarisAvenueCamanaBayGrandCaymanKY1-1108,开曼群岛召开2025年第一次临时股东大会。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202503103341575117.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503103341575117.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1500","BK4139","LU0307460666.USD","BK1588","ONC","06160","BK1583","LU2328871848.SGD","LU1969619763.USD","BK1161","LU0588546209.SGD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.beigene.cn","stockEarnings":[{"period":"1week","weight":0.031},{"period":"1month","weight":-0.0386},{"period":"3month","weight":0.1527},{"period":"6month","weight":0.158},{"period":"1year","weight":0.877},{"period":"ytd","weight":0.369}],"compareEarnings":[{"period":"1week","weight":0.0045},{"period":"1month","weight":-0.0898},{"period":"3month","weight":0.0902},{"period":"6month","weight":0.0524},{"period":"1year","weight":0.3059},{"period":"ytd","weight":0.0749}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"BeiGene Ltd是一家全球生物技术公司,致力于为全球癌症患者发现和开发肿瘤治疗方法。该公司已发现并开发三种批准药物,包括BRUKINSA,一种布鲁顿酪氨酸激酶的小分子抑制剂,用于治疗各种血癌;TEVIMBRA(tislelizumab),一种抗PD-1抗体免疫疗法,用于治疗各种实体瘤和血癌;以及是聚ADP核糖聚合酶1(PARP1)和PARP2的选择性小分子抑制剂pamiparib。该公司已获得在美国、中华人民共和国(中国)、欧盟、英国、加拿大、澳大利亚和其他国际市场销售BRUKINSA,在欧盟和中国销售替雷利珠单抗,以及在中国销售帕米帕尼的批准。它还专注于在Amgen Inc独家授权下在中国商业化癌症药物,如XGEVA、BLINCYTO、KYPROLIS等。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.009815},{"month":2,"riseRate":0.571429,"avgChangeRate":0.046604},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.052519},{"month":4,"riseRate":0.428571,"avgChangeRate":0.030203},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.053583},{"month":6,"riseRate":0.5,"avgChangeRate":0.011188},{"month":7,"riseRate":0.833333,"avgChangeRate":0.075403},{"month":8,"riseRate":0.833333,"avgChangeRate":0.065797},{"month":9,"riseRate":0.428571,"avgChangeRate":0.01247},{"month":10,"riseRate":0.571429,"avgChangeRate":-0.017395},{"month":11,"riseRate":0.571429,"avgChangeRate":0.120457},{"month":12,"riseRate":0.142857,"avgChangeRate":-0.068807}],"exchange":"SEHK","name":"百济神州","nameEN":"BEIGENE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百济神州(06160)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百济神州(06160)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百济神州,06160,百济神州股票,百济神州股票老虎,百济神州股票老虎国际,百济神州行情,百济神州股票行情,百济神州股价,百济神州股市,百济神州股票价格,百济神州股票交易,百济神州股票购买,百济神州股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百济神州(06160)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百济神州(06160)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}